In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Abivax ADR (NASDAQ: ABVX) closed at $100.9 down -2.45% from its previous closing price of $103.43. In other words, the price has decreased by -$2.45 from its previous closing price. On the day, 0.7 million shares were traded. ABVX stock price reached its highest trading level at $105.53 during the session, while it also had its lowest trading level at $100.5.
Ratios:
For a deeper understanding of Abivax ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Wolfe Research on November 06, 2025, initiated with a Outperform rating and assigned the stock a target price of $176.
On October 13, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $142.
Morgan Stanley Upgraded its Equal-Weight to Overweight on July 23, 2025, while the target price for the stock was maintained at $71.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 28 ’25 when Sofinnova Crossover I SLP bought 1,200,000 shares for $92.75 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABVX now has a Market Capitalization of 8187961856 and an Enterprise Value of 6442080256. Its current Enterprise Value per Revenue stands at 1069.58 whereas that against EBITDA is -34.7.
Stock Price History:
The Beta on a monthly basis for ABVX is 0.76, which has changed by 9.887368 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, ABVX has reached a high of $109.71, while it has fallen to a 52-week low of $4.77. The 50-Day Moving Average of the stock is 10.55%, while the 200-Day Moving Average is calculated to be 163.40%.
Shares Statistics:
For the past three months, ABVX has traded an average of 1.07M shares per day and 1086820 over the past ten days. A total of 77.83M shares are outstanding, with a floating share count of 70.27M. Insiders hold about 11.68% of the company’s shares, while institutions hold 30.88% stake in the company. Shares short for ABVX as of 1761868800 were 1715643 with a Short Ratio of 1.60, compared to 1759190400 on 1241792. Therefore, it implies a Short% of Shares Outstanding of 1715643 and a Short% of Float of 2.6099999.
Earnings Estimates
The stock of Abivax ADR (ABVX) is currently drawing attention from 1 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.61, with high estimates of -$0.61 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$3.06 and -$3.63 for the fiscal current year, implying an average EPS of -$3.41. EPS for the following year is -$2.92, with 4.0 analysts recommending between -$2.05 and -$3.75.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $1.28M. There is a high estimate of $1.28M for the next quarter, whereas the lowest estimate is $1.28M.
